This may also be explained by the fact that the disease diagnosis and thus the classification of individuals in PD− and PD+ is based on multiple clinical criteria, resulting in more heterogeneous populations than classification in LRRK2− and LRRK2+ based on sequencing of the locus. This evidence concerns the gene LRRK2 and Parkinson disease.